Eris Lifesciences Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.068x

Eris Lifesciences Limited cash flow conversion efficiency. Based on the latest financial reports, Eris Lifesciences Limited (ERIS) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.39 Billion ≈ $25.85 Million USD) by net assets (Rs35.03 Billion ≈ $378.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Eris Lifesciences Limited (2012–2026)

Cash flow conversion efficiency of Eris Lifesciences Limited from 2012 to 2026. This chart illustrates how Eris Lifesciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Eris Lifesciences Limited for real-time trading data and today's change.

Eris Lifesciences Limited Cash Flow Conversion Ratio Explained

Eris Lifesciences Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Eris Lifesciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eris Lifesciences Limited ranked by their cash flow conversion efficiency. Also see Eris Lifesciences Limited (ERIS) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hyundai Doosan Infracore Co Ltd KO:042670	0.072x
Syngene International Limited NSE:SYNGENE	-0.010x
Nanjing Sunlord Electronics Corporation LTD SHE:300975	-0.001x
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	-0.094x
SK Bioscience Co Ltd KO:302440	0.010x
A10 Network NYSE:ATEN	0.122x
Genesis Energy LP NYSE:GEL	0.153x
Charter Hall Long Wale REIT AU:CLW	0.027x

Annual Cash Flow Conversion Efficiency for Eris Lifesciences Limited (2012–2026)

The table below shows the annual cash flow conversion efficiency of Eris Lifesciences Limited from 2012 to 2026. Review ERIS cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs38.96 Billion ≈ $421.30 Million	Rs3.47 Billion ≈ $37.52 Million	0.089x	-72.64%
2025-03-31	Rs32.72 Billion ≈ $353.83 Million	Rs10.65 Billion ≈ $115.18 Million	0.326x	+115.80%
2024-03-31	Rs32.22 Billion ≈ $348.45 Million	Rs4.86 Billion ≈ $52.56 Million	0.151x	+14.82%
2023-03-31	Rs22.21 Billion ≈ $240.16 Million	Rs2.92 Billion ≈ $31.55 Million	0.131x	-33.73%
2022-03-31	Rs19.08 Billion ≈ $206.36 Million	Rs3.78 Billion ≈ $40.91 Million	0.198x	-16.75%
2021-03-31	Rs15.76 Billion ≈ $170.48 Million	Rs3.75 Billion ≈ $40.59 Million	0.238x	+13.85%
2020-03-31	Rs12.96 Billion ≈ $140.19 Million	Rs2.71 Billion ≈ $29.32 Million	0.209x	+9.62%
2019-03-31	Rs11.69 Billion ≈ $126.40 Million	Rs2.23 Billion ≈ $24.12 Million	0.191x	-27.96%
2018-03-31	Rs8.86 Billion ≈ $95.81 Million	Rs2.35 Billion ≈ $25.37 Million	0.265x	-28.46%
2017-03-31	Rs5.40 Billion ≈ $58.39 Million	Rs2.00 Billion ≈ $21.61 Million	0.370x	-8.77%
2016-03-31	Rs3.24 Billion ≈ $35.04 Million	Rs1.31 Billion ≈ $14.22 Million	0.406x	+21.46%
2015-03-31	Rs2.70 Billion ≈ $29.16 Million	Rs900.57 Million ≈ $9.74 Million	0.334x	-32.59%
2014-03-31	Rs1.81 Billion ≈ $19.56 Million	Rs896.24 Million ≈ $9.69 Million	0.496x	+44.48%
2013-03-31	Rs1.11 Billion ≈ $11.99 Million	Rs380.15 Million ≈ $4.11 Million	0.343x	-40.12%
2012-03-31	Rs528.98 Million ≈ $5.72 Million	Rs302.99 Million ≈ $3.28 Million	0.573x	--

About Eris Lifesciences Limited

NSE:ERIS India Drug Manufacturers - Specialty & Generic

Market Cap

$1.77 Billion

Rs163.21 Billion INR

Market Cap Rank

#6336 Global

#290 in India

Share Price

Rs1177.70

Change (1 day)

+1.51%

52-Week Range

Rs1095.50 - Rs1701.30

All Time High

Rs1847.70